Citi Initiates 90-Day Watch on Zimmer Biomet (ZBH) Ahead of Q3 Earnings

gurufocus.com · 2026-10-05

On October 05, 2026, Citi analyst Joanne Wuensch initiated a 90-day watch on Zimmer Biomet Holdings Inc (NYSE: ZBH), maintaining a Neutral rating with a target

TickrTrends take: Zimmer Biomet operates in the Healthcare sector where Citi's decision to initiate a 90-day watch period suggests upcoming catalysts that could influence the company's valuation trajectory. TickrTrends currently rates ZBH as undervalued, which means investors following the analyst's watch period may be positioned to observe how Q3 earnings results either validate or challenge that assessment. The combination of elevated analyst scrutiny and an undervalued designation indicates this period could present significant movements in how the market prices the company's fundamentals.

Read the full story at gurufocus.com →